Insight for strategy that delivers
|5th April 2016
Healthcare is changing. Developments in treatments are taking place faster than ever, more stakeholders are involved in making decisions around treatments, and these stakeholders have different, sometimes conflicting needs. In this context, insight is key to effective marketing in meeting the challenge to deliver value to an ever-broadening range of stakeholders.
In this article, Head of Commercial Matt Bolton and Head of Insight Martine Leroy talk through how insight informs strategy at Blue Latitude Health.
What do we mean by ‘insight’?
At Blue Latitude Health, we regard insight as the deep understanding of the space where external and internal customers meet. In this context, we refer to external customers as those making decisions that impact the success of your product or service, be they patients, physicians, payers, nurses or others. Internal customers refer to those members of a healthcare company that must be engaged and motivated to deliver for external customers, from the brand team, to capability leads or compliance. Gathering insight in this sense allows us the opportunity to identify where external customers expect the business to operate and to deliver, and importantly where internal customers want and are able to operate. After all, insight is only useful if it can be acted upon.
Read more about customer-centric strategy and design in issue 2 of Perspective magazine:
Mobilising the public to combat the antimicrobial resistance crisis
|11th January 2019
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. So why doesn’t the public seem bothered? BLH Account Executive Ford Stewart examines this issue and explores what we could do to spark behaviour change.
Q&A with Dr Timothy Vollmer, leading MS Neurologist
|11th December 2018
Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.
Report: Achieving launch excellence in the challenging healthcare markets of today
|10th December 2018
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging markets.